United States Healthcare Equipment & Supplies

Meridian Bioscience Inc (VIVO)

Track

Meridian Bioscience Inc has not recorded any insider trading activity within the last three months. The most recent transactions occurred in June 2022, involving planned sales of shares by the Chief Executive Officer, John P. Kenny. Prior to that, various executives engaged in both buying and selling activities throughout early 2022 and 2021.
Ticker: VIVO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Meridian Bioscience Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 27 Jun 2022
Value US$2,534,146.10 | Price 303.28 | Shares 27,018 (+2.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-28 2022-06-27 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
27,018 +2.2%
303.28
US$2,534,146 		27,018 +2.2% 303.28 US$2,534,146
2022-06-28 2022-06-24 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
66,262 -26.6%
390.53
US$3,870,623 		66,262 -26.6% 390.53 US$3,870,623
2022-06-24 2022-06-23 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
51,331 -4.7%
71.78
US$2,774,426 		51,331 -4.7% 71.78 US$2,774,426
2022-06-24 2022-06-22 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
44,651 -14.4%
29.72
US$1,326,921 		44,651 -14.4% 29.72 US$1,326,921
2022-02-28 2022-02-25 B Purchase
2.9
Kitzmiller Andrew S.

EVP & CFO

Officer
4,028 +53.7%
24.87
US$100,166 		4,028 +53.7% 24.87 US$100,166
2022-02-17 2022-02-15 S Sale
1.6
WELTZIEN LOURDES

EVP, Life Science

Officer
20,000 -19.4%
25.60
US$511,912 		20,000 -19.4% 25.60 US$511,912
2021-03-18 2021-03-17 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
30,000 -12.6%
25.00
US$750,000 		30,000 -12.6% 25.00 US$750,000
2021-03-11 2021-03-10 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
10,000 -4.0%
25.00
US$250,000 		10,000 -4.0% 25.00 US$250,000
2021-02-17 2021-02-16 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
2,359 -0.9%
30.35
US$71,604 		2,359 -0.9% 30.35 US$71,604
2021-02-16 2021-02-12 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
26,181 -9.5%
30.14
US$789,085 		26,181 -9.5% 30.14 US$789,085
2021-02-16 2021-02-11 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
1,320 -0.5%
30.00
US$39,601 		1,320 -0.5% 30.00 US$39,601
2021-02-10 2021-02-08 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
68,288 -21.3%
29.86
US$2,039,114 		68,288 -21.3% 29.86 US$2,039,114
2021-02-09 2021-02-08 PlS Planned sale
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
6,254 -10.0%
30.00
US$187,620 		6,254 -10.0% 30.00 US$187,620
2021-02-09 2021-02-08 S Sale
3.5
Rice John McCune Jr.
Non-Executive Director
16,480 -40.3%
28.16
US$464,008 		16,480 -40.3% 28.16 US$464,008
2021-02-08 2021-02-05 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 -7.3%
25.00
US$500,000 		20,000 -7.3% 25.00 US$500,000
2021-02-08 2021-02-05 PlS Planned sale
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
14,250 -19.6%
26.61
US$379,126 		14,250 -19.6% 26.61 US$379,126
2021-02-08 2021-02-05 PlS Planned sale
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 -6.8%
25.00
US$500,000 		20,000 -6.8% 25.00 US$500,000
2020-11-30 2020-11-25 B Purchase
3.4
Bihl Anthony P III
Non-Executive Director
5,000 +85.5%
17.65
US$88,266 		5,000 +85.5% 17.65 US$88,266
2020-03-17 2020-03-16 B Purchase
3.7
Williams Felicia
Non-Executive Director
1,550 +37.2%
6.02
US$9,331 		1,550 +37.2% 6.02 US$9,331
2020-03-13 2020-03-12 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
30,000 +14.4%
5.78
US$173,541 		30,000 +14.4% 5.78 US$173,541
2020-03-11 2020-03-10 B Purchase
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
1,000 +1.9%
6.96
US$6,955 		1,000 +1.9% 6.96 US$6,955
2020-03-11 2020-03-10 B Purchase
3.4
Baldasare Bryan T

Exec VP & CFO

Officer
1,000 +2.0%
6.98
US$6,981 		1,000 +2.0% 6.98 US$6,981
2020-02-26 2020-02-25 B Purchase
2.5
McIlwraith John
Non-Executive Director
5,000 +41.1%
7.59
US$37,950 		5,000 +41.1% 7.59 US$37,950
2020-02-26 2020-02-24 B Purchase
3.5
Rice John McCune Jr.
Non-Executive Director
3,000 +32.7%
7.52
US$22,547 		3,000 +32.7% 7.52 US$22,547
2020-02-24 2020-02-21 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
10,000 +5.0%
7.65
US$76,546 		10,000 +5.0% 7.65 US$76,546
2019-11-13 2019-11-12 B Purchase PHILLIPS DAVID Non-Executive Director
10,000 +25.9%
8.06
US$80,626 		10,000 +25.9% 8.06 US$80,626
2019-11-12 2019-11-08 B Purchase Kenny John P.

Chief Executive Officer

Executive Director
20,000 +11.2%
7.73
US$154,588 		20,000 +11.2% 7.73 US$154,588
2019-05-23 2019-05-22 B Purchase
3.5
Rice John McCune Jr.
2,000 +50.2%
11.26
US$22,516 		2,000 +50.2% 11.26 US$22,516
2019-05-20 2019-05-16 B Purchase
1.5
Anderson James M.
5,000 +71.6%
11.37
US$56,855 		5,000 +71.6% 11.37 US$56,855
2019-05-13 2019-05-13 B Purchase
1.5
PHILLIPS DAVID
Non-Executive Director
5,000 +15.0%
11.40
US$57,015 		5,000 +15.0% 11.40 US$57,015
2019-05-09 2019-05-08 B Purchase
3.5
Kenny John P.

Chief Executive Officer

Executive Director
20,000 +31.7%
11.49
US$229,744 		20,000 +31.7% 11.49 US$229,744
2019-02-25 2018-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
31 +0.4%
18.42
US$571 		31 +0.4% 18.42 US$571
2018-11-14 2018-11-13 S Sale BALDINI LAWRENCE

EVP, Global Operations

Officer
9,876 -13.0%
19.55
US$193,047 		9,876 -13.0% 19.55 US$193,047
2018-11-14 2018-11-12 S Sale BALDINI LAWRENCE

EVP, Global Operations

Officer
25,225 -24.9%
19.35
US$488,182 		25,225 -24.9% 19.35 US$488,182
2018-08-28 2018-08-24 B Purchase McIlwraith John Non-Executive Director
2,000 +50.0%
15.63
US$31,250 		2,000 +50.0% 15.63 US$31,250
2019-02-25 2018-08-16 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.5%
14.91
US$567 		38 +0.5% 14.91 US$567
2019-02-25 2018-05-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
40 +0.5%
13.88
US$555 		40 +0.5% 13.88 US$555
2018-02-26 2018-02-23 B Purchase McIlwraith John Non-Executive Director
1,000 +33.3%
14.03
US$14,034 		1,000 +33.3% 14.03 US$14,034
2019-02-25 2018-02-13 B Purchase
Ellingwood Dwight E
Non-Executive Director
39 +0.5%
14.13
US$551 		39 +0.5% 14.13 US$551
2018-02-07 2018-02-07 B Purchase Rice John McCune Jr. Non-Executive Director
1,000 +inf%
14.75
US$14,750 		1,000 +inf% 14.75 US$14,750
2019-02-25 2017-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.5%
14.56
US$553 		38 +0.5% 14.56 US$553
2017-08-25 2017-08-24 B Purchase KRAEUTLER JOHN A

Chairman and CEO

Executive Director
7,000 +2.1%
13.67
US$95,694 		7,000 +2.1% 13.67 US$95,694
2019-02-25 2017-08-14 B Purchase
Ellingwood Dwight E
Non-Executive Director
39 +0.5%
13.94
US$544 		39 +0.5% 13.94 US$544
2019-02-25 2017-05-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
36 +0.5%
14.90
US$536 		36 +0.5% 14.90 US$536
2019-02-25 2017-02-13 B Purchase
Ellingwood Dwight E
Non-Executive Director
41 +0.6%
12.93
US$530 		41 +0.6% 12.93 US$530
2017-02-03 2017-02-02 B Purchase LUEKE MELISSA

Exec VP, CFO

Officer
4,000 +2.5%
12.59
US$50,356 		4,000 +2.5% 12.59 US$50,356
2017-01-30 2017-01-26 B Purchase BALDINI LAWRENCE

EVP, Pres Global Operations

Officer
4,000 +3.9%
12.70
US$50,800 		4,000 +3.9% 12.70 US$50,800
2016-12-05 2016-12-02 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
7,883 -13.0%
17.30
US$136,376 		7,883 -13.0% 17.30 US$136,376
2016-12-01 2016-11-30 B Purchase Ellingwood Dwight E Non-Executive Director
1,020 +17.1%
17.12
US$17,466 		1,020 +17.1% 17.12 US$17,466
2019-02-25 2016-11-28 B Purchase
Ellingwood Dwight E
Non-Executive Director
38 +0.6%
17.07
US$648 		38 +0.6% 17.07 US$648
2016-11-18 2016-11-16 S Sale EBERLY RICHARD

EVP; Pres, Chief Comm Officer

Officer
4,926 -9.2%
17.00
US$83,757 		4,926 -9.2% 17.00 US$83,757
2016-11-07 2016-11-04 B Purchase KRAEUTLER JOHN A

Chairman and CEO

Executive Director
5,000 +1.6%
16.13
US$80,666 		5,000 +1.6% 16.13 US$80,666
2016-11-07 2016-11-03 B Purchase BALDINI LAWRENCE

EVP, Pres Global Operations

Officer
4,900 +5.4%
16.00
US$78,400 		4,900 +5.4% 16.00 US$78,400
2019-02-25 2016-08-15 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +0.5%
19.50
US$624 		32 +0.5% 19.50 US$624
2016-08-15 2016-08-11 B Purchase McIlwraith John Non-Executive Director
1,000 +50.0%
19.57
US$19,565 		1,000 +50.0% 19.57 US$19,565
2019-02-25 2016-05-16 B Purchase
Ellingwood Dwight E
Non-Executive Director
33 +1.1%
19.06
US$629 		33 +1.1% 19.06 US$629
2016-05-02 2016-04-29 B Purchase Sazdanoff Catherine Non-Executive Director
7,700 +inf%
19.20
US$147,844 		7,700 +inf% 19.20 US$147,844
2019-02-25 2016-02-12 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.0%
19.62
US$628 		32 +1.0% 19.62 US$628
2015-12-10 2015-12-09 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
7,500 -12.1%
19.75
US$148,125 		7,500 -12.1% 19.75 US$148,125
2015-12-02 2015-12-01 S Sale EBERLY RICHARD

EVP,Pres Meridian Life Science

Officer
4,934 -9.6%
19.61
US$96,740 		4,934 -9.6% 19.61 US$96,740
2019-02-25 2015-11-23 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.0%
19.27
US$617 		32 +1.0% 19.27 US$617
2015-11-24 2015-11-06 B Purchase McIlwraith John Non-Executive Director
1,000 +100.0%
20.19
US$20,187 		1,000 +100.0% 20.19 US$20,187
2019-02-25 2015-08-10 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.1%
18.69
US$598 		32 +1.1% 18.69 US$598
2019-02-25 2015-05-11 B Purchase
Ellingwood Dwight E
Non-Executive Director
32 +1.1%
18.51
US$592 		32 +1.1% 18.51 US$592
2015-03-03 2015-03-02 S Sale Johnson Marviette D.

VP, Human Resources

Officer
1,917 -3.9%
19.91
US$38,169 		1,917 -3.9% 19.91 US$38,169
2019-02-25 2015-02-10 B Purchase
Ellingwood Dwight E
Non-Executive Director
33 +1.1%
18.20
US$601 		33 +1.1% 18.20 US$601
2015-01-26 2015-01-23 B Purchase Ellingwood Dwight E Non-Executive Director
1,980 +198.0%
17.74
US$35,126 		1,980 +198.0% 17.74 US$35,126
2014-12-02 2014-12-01 S Sale ROLIH SUSAN

EVP, Reg & Quality Systems

Officer
11,219 -8.8%
16.46
US$184,667 		11,219 -8.8% 16.46 US$184,667
2014-11-26 2014-11-24 S Sale EBERLY RICHARD

EVP,Pres Meridian Life Science

Officer
4,539 -9.7%
16.07
US$72,963 		4,539 -9.7% 16.07 US$72,963
2014-11-24 2014-11-21 B Purchase Ellingwood Dwight E Non-Executive Director
1,000 +inf%
16.08
US$16,083 		1,000 +inf% 16.08 US$16,083
2014-11-20 2014-11-18 S Sale KRAEUTLER JOHN A

Chairman and CEO

Executive Director
10,500 -3.7%
16.20
US$170,108 		10,500 -3.7% 16.20 US$170,108
2014-11-20 2014-11-18 S Sale LUEKE MELISSA

Exec VP, CFO

Officer
6,713 -4.8%
16.20
US$108,751 		6,713 -4.8% 16.20 US$108,751
2014-11-12 2014-11-11 B Purchase PHILLIPS DAVID Non-Executive Director
10,000 +96.0%
16.89
US$168,924 		10,000 +96.0% 16.89 US$168,924
2014-06-16 2014-06-13 S Sale READY ROBERT J Non-Executive Director
2,700 -16.5%
20.03
US$54,094 		2,700 -16.5% 20.03 US$54,094
2013-12-06 2013-12-05 S Sale Elagin Vecheslav A

EVP, Research & Development

Officer
4,141 -7.6%
23.74
US$98,296 		4,141 -7.6% 23.74 US$98,296
Explore more

More insider trading research around Meridian Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America